Absorption and metabolism of the absorption enhancer didecanoylphosphatidylcholine in rabbit nasal epithelium in vivo

Drug Metabolism and Disposition

Volumn 25, Issue 9, 1997, Pages 1083-1088

  Vermehren, Charlotte ^a   Johansen, Peter B ^b   Hansen, Harald S ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG METABOLISM; INTRANASAL DRUG ADMINISTRATION; ISOTOPE LABELING; LIPID ABSORPTION; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, INTRANASAL; ANIMALS; EPITHELIUM; NASAL MUCOSA; PHOSPHATIDYLCHOLINES; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0030821968     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. B. J. Aungst, N. J. Rogers, and E. Shelter: Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J. Pharmacol. Exp. Ther. 244, 23-27 (1988).
2. H. Zia, P. Dondeti, and T. E. Needham: Intranasal drug delivery. Clin. Res. Reg. Affairs 10, 99-135 (1993).
3. X. H. Zhou: Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. J. Controlled Release 29, 239-252 (1994).
4. Y. W. Chien and S.-F. Chang: Intranasal drug delivery for systemic medications. Crit. Rev. Ther. Drug Carrier Syst. 4, 67-194 (1987).
5. C. McMartin, L. E. F. Hutchinson, R. Hyde, and G. E. Peters: Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J. Pharm. Sci. 76, 535-540 (1987).
6. S. Hirai, T. Yashiki, and H. Mima: Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm. 9, 173-184 (1981).
7. E. Ziv. O. Lior, and M. Kidron: Absorption of protein via the intestinal wall. A quantitative model. Biochem. Pharmacol. 36, 1035-1039 (1987).
8. D. T. O'Hagan and L. Ilium: Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine. Crit. Rev. Ther. Drug. Carrier Syst. 7, 35-97 (1990).
9. P. Hansen, K. Drejer, A. Engesgaard, B. Guldhammer, R. K. Hjortkjaer, N. Mygind, and A. R. Sørensen: Medium chain phospholipid enhance the transnasal absorption of insulin. Diabetes Res. Clin. Pract. 5, S164 (1988).
10. C. Vermehren, H. S. Hansen, and M. K. Thomsen: Time dependent effects of two absorption enhancers on the nasal absorption of growth hormone in rabbits. Int. J. Pharmaceut. 128, 239-250 (1996).
11. C. Agerholm, L. Bastholm, P.B. Johansen, M. H. Nielsen, and F. Elling: Epithelial transport and bioavailability of intranasal growth hormone formulated with the absorption enhancers didecanoyl-L-α-phosphatidylcholine and α-cyclodextrin in rabbit. J. Pharmaceut. Sci. 83, 1706-1711 (1994).
12. A.W. Lee and J. P. Longenecker: Intranasal delivery of proteins and peptides. Biopharm Manufacturing 1, 30-37 (1988).
13. R. E. Stafford and E. A. Dennis: Lysophospholipids as biosurfactants. Colloids and Surfaces 30, 47-64 (1988).
14. S. Carstens, G. Danielsen, B. Guldhammer, and O. Frederiksen: Transport of insulin across rabbit nasal mucosa in vitro induced by didecanoyl-L-α-phosphatidylcholine. Diabetes 42, 1032-1040 (1993).
15. D. J. Canty and S. H. Zeisel: Lecithin and choline in human health and disease. Nutr. Rev. 52, 327-339 (1994).
16. C. Vermehren, H. S. Hansen, and M. K. Thomsen: Metabolism and effects of a phospholipid absorption enhancer in rabbit nasal epithelium in vitro. In "Phospholipids: Characterization, Metabolism, and Novel Biological Applications" (G. Cevc and F. Paltauf, eds.), pp. 80-100. AOCS Press, Champaign, IL, 1995.
17. A. Fisher, C. Dodia, and A. Chander: Alveolar uptake of lipid and protein components of surfactant. Am. J. Physiol. 261, L334-L340 (1991).
18. G. Schmilz and G. Muller: Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J. Lipid Res. 32, 1539-1570 (1991).
19. H. Jacobs, A. Jobe, M. Ikegami, D. Miller, and S. Jones: Reutilization of phosphatidylcholine analogues by the pulmonary surfactant system. The lack of system. Biochim. Biophys. Acta 793, 300-309 (1984).
20. J. R. Silvius and R. Leventis: Spontaneous interbilayer transfer of phospholipids: dependence on acyl chain composition. Biochemistry 32, 13318-13326 (1993).
21. S. C. Morash, H. W. Cook, and M. W. Spence: Phosphatidylcholine metabolism in cultured cells: catabolism via glycerophosphatidylcholine. Biochim. Biophys. Acta 961, 194-202 (1988).
22. L. C. Dubrovin and A. S. Brown: Stimulation of phosphatidylcholine hydrolysis in type II alveolar epithelial cells. Am. J. Physiol. 263, L42-L50 (1992).
23. 2 in rat renal mesangial cells. J. Biol. Chem. 263, 16645-16651 (1988).
24. M. F. Roberts: Assays of phospholipases on short-chain phospholipids. Methods Enzymol. 197, 95-112 (1991).
25. A. M. Vinggaard, T. Jensen, C. P. Morgan, S. Cockeroft, and H. S. Hansen: Didecanoylphosphatidylcholine is a superior substrate for assaying mammalian phospholipase D. Biochem. J. 319, 861-864 (1996).
26. M. Røpke: Effects of a short-chain phospholipid on ion transport pathways in rabbit nasal airway epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 271, L646-L655 (1996).
27. 2(s); comparison of arachidonoyl-selective and -nonselective enzymes. FASEB J. 7, 339-348 (1993).
28. 2 from human nasal lavage. Am. J. Respir. Cell Mol. Biol. 11, 108-113 (1994).
29. A. Chander, W. D. Claypool, Jr., J. F. Strauss, III, and A. B. Fisher: Uptake of liposomal phosphatidylcholine by granular pneumocytes in primary culture. Am. J. Physiol. 245, C397-C404 (1983).
30. R. M. Abra and P. J. Quinn: A novel pathway for phosphatidylcholine catabolism in rat brain homogenates. Biochim. Biophys. Acta 380, 436-441 (1975).
31. J. I. S. MacDonald and H. Sprecher: Phospholipid fatty acid remodeling in mammalian cells. Biochim. Biophys. Acta 1084, 105-121 (1991).
32. M. G. Sarzala and L. M. G. Van Golde: Selective utilization of endogenous unsaturated phosphatidylcholines and diacylglycerols by cholinephosphotransferase of mouse lung microsomes. Biochim. Biophys. Acta 441, 423-432 (1976).
33. A. B. Fisher, C. Dodia, and A. Chander: Degradation and reutilization of alveolar phosphatidylcholine by rat lungs. J. Appl. Physiol. 62, 2295-2299 (1987).
34. P. Ott, J. M. Hope, A. J. Verkleij, B. Roelofsen, U. Brodbeck, and L. L. M. van Deenen: Effect of dimyristoyl phosphatidylcholine on intact erythrocytes. Release of spectrin-free vesicles without ATP depletion. Biochim. Biophys. Acta 641, 79-87 (1981).
35. B. Roelofsen, F. A. Kuypers, J. A. F. Op den Kamp, and L. L. M. van Deenen: Influence of phosphatidylcholine molecular species composition on stability of the erythrocyte membrane. Biochem. Soc. Trans. 17, 284-286 (1989).
36. J. L. Madara, D. Barenberg, and S. Carlson: Effects on cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J. Cell Biol. 102, 2125-2136 (1986).
37. E. Bechgaard, L. Jørgensen, R. Larsen, S. Gizurarson, J. Carstensen, and Aa. Hvass: Insulin and didecanoyl-L-α-phosphatidylcholine in vitro study of the transport through rabbit nasal mucosal tissue. Int. J. Pharmaceut. 89, 147-153 (1993).
38. M. Mishima, Y. Wakita, and M. Nakano: Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats. J. Pharmarobiodyn. 10, 624-631 (1987).
39. A. Yamamoto, T. Morita, M. Hashida, and H. Sezaki: Effect of absorption promoters on the nasal absorption of drugs with various molecular weights. Int. J. Pharmaceut. 93, 91-99 (1993).